Forxiga Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
Conditions:   Breast Cancer;   Hyperinsulinism;   HER2-negative Breast Cancer Intervention:   Drug: Dapagliflozin 10mg Sponsors:   Yale University;   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Dapagliflozin 10mg Tab Sponsor:   Mostafa Bahaa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
Conditions:   Breast Cancer;   Hyperinsulinism;   HER2-negative Breast Cancer Intervention:   Drug: Dapagliflozin 10mg Sponsors:   Yale University;   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Dapagliflozin 10mg Tab Sponsor:   Mostafa Bahaa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
Conditions:   Breast Cancer;   Hyperinsulinism;   HER2-negative Breast Cancer Intervention:   Drug: Dapagliflozin 10mg Sponsors:   Yale University;   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Dapagliflozin 10mg Tab Sponsor:   Mostafa Bahaa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
Conditions:   Breast Cancer;   Hyperinsulinism;   HER2-negative Breast Cancer Intervention:   Drug: Dapagliflozin 10mg Sponsors:   Yale University;   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Dapagliflozin 10mg Tab Sponsor:   Mostafa Bahaa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
Conditions:   Breast Cancer;   Hyperinsulinism;   HER2-negative Breast Cancer Intervention:   Drug: Dapagliflozin 10mg Sponsors:   Yale University;   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2023 Category: Research Source Type: clinical trials